Discover how transperineal prostate biopsy under local anaesthesia delivers high diagnostic yield safely and without ...
TORONTO, Nov. 5, 2019 /PRNewswire-PRWeb/ -- Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it has received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy ...
Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu(TM) micro-ultrasound platform to MRI fusion-guided biopsy for diagnosing prostate ...
SAN FRANCISCO—Prostate cancer (PCa) detection rates may be markedly improved by adding targeted fusion biopsy to conventional blind random biopsies, according to a new study presented at the 37th ...
GRENOBLE, France and PRINCETON, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today the ...
Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...
Testosterone Therapy for Severe Hypogonadism Improves Sexual Function In patients undergoing confirmatory biopsy for active surveillance, MRI can increase detection of clinically significant tumors ...
In a new health technology assessment, the U.K. National Institute for Health and Care Excellence (NICE) has voiced misgivings about the evidence behind the use of MRI/ultrasound fusion systems to ...
Matthew Parsons, Bridget Foy, Ernest Chan, Bryan Crawford, Daniel Sommers, Jay Bishoff, Steven C. Lynch, Benjamin Romney, David Michael Gill, and Logan McLean Journal of Clinical Oncology Share on ...
The prostate, a vital part of the male reproductive system, is susceptible to cancer. Prostate cancer is concerning for many men, particularly as they age. It stands as one of the most common cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback